Professional Documents
Culture Documents
Are We Prepared For Biological Terror?: Nature and Duality
Are We Prepared For Biological Terror?: Nature and Duality
Are We Prepared For Biological Terror?: Nature and Duality
Duality is fundamental
Technology Generation
Area First Second Third Fourth
chemical testing, urea for genome analysis, linked to
Diagnostics example
Enzyme-linked immuno-assays PCR-based DNA assays
preventive intervention
rationally derived cellular and gene therapies
chemical substances, antibiotics, therapies based on pharmaceuticals, from rDNA directed primarily to the
Therapeutics biologicals isolated from biochemical or physiological and combinatorial chemistry, individual. New therapies
human and animal sources rationale sophisticated peptides and resulting from intermediary
hormones metabolism studies
rDNA rationally attenuated therapeutic vaccines, cancer
live attenuated vaccines,
Protection whole cell killed vaccines
purified antigen vaccines
vaccines, rDNA-derived vaccines, vaccines as
antigens mediators of gene therapy
modulation of immune system
skin grafting, kidney to control rejection.
transplantation between widespread use of xenografting, in-vitro tissue
Human materials blood transfusion relatives, improved tissue transplantation technologies. and organ growth, effective
typing, isolation of plasma- Replacement of human and safe blood substitutes.
derived products materials by recombinant
analogues.
Complete integration of
Related bunsun burners, test tubes, analysis operations in robotic, Full instrumentation package
microprocessor controlled
colorimeters, PC-controlled instrument with on a "chip". RISC PC control.
instrument spectrophotometers, manual
instruments. Sample volumes
individual microprocessor Up to 000s of analyses.
down to less than 1 ml.
development operation controlled modules. Volumes Sample volumes sub microlitre.
down to tens of microlitres.
In my view - NO!
And NO again!
Why should the rich world have a say in how Iran
or Egypt develop vaccines? Our record is not
good. Where are the vaccines for malaria, AIDS,
or TB? Where are the plans for generating
economic growth in the most needy of nations?
We create enemies!
Government/Industrial collaboration
European and US industry lead the world in
vaccine development capability, fermentation
technologies and fast response to challenges.
Together with public health laboratories and
academic research, industry can act quickly to
respond or to anticipate an epidemic disease
manifestation.
Government must catalyse the relevant dialogue
through structured initiatives that offer sensible
incentives to industrial and public sector partners.
Conclusions
• Dual use potential is everywhere
• However, the risk in the area of modern biology
is - I believe - exaggerated
• The naturally emerging Next Virus may be
deadly
• Industry has capability but little incentive to be
prepared - dual-use issues are a constraint!
• Sensible application of a BTWC protocol,
coupled with minor reinforcement of existing
regulatory regimes could avoid dual-abuse.
Karl Simpson
Bénézech - Simpson
Hameau de Bobon
07610 VION
France
Tel: +33-4-75 06 86 30
E-Mail: karl@simpson.nom.fr
http://www.simpson.nom.fr